Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Immuneering Advances Towards Dosing First Patient in Phase 3 Atebimetinib Trial, Securing Alignment with FDA and EMA
-
Immuneering to Present at the Piper Sandler 37th Annual Healthcare Conference
-
Immuneering Announces Clinical Supply Agreement with Lilly to Evaluate Atebimetinib in Combination with Olomorasib
-
Immuneering to Present at the Jefferies Global Healthcare Conference
-
Immuneering Reports First Quarter 2025 Financial Results and Provides Business Updates
-
Austin, TX, USA, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Mining Equipment Market Size, Trends and Insights By Equipment Type (Surface...
-
Data Presented at the NeuroCritical Care Society 19th Annual Meeting 2021 Data Highlight Daxor’s Diagnostic Changes Care in 69% of Patients With Non-Traumatic Subarachnoid Hemorrhage (nSAH) NEW...
-
Barcelona, SPAIN, March 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- At Mobile World Congress (MWC) 2019, Huawei unveiled their next-generation Data Center Interconnect (DCI) transmission...
-
VANCOUVER, BC--(Marketwire - September 14, 2010) - BroadMotion today announced support of its JPEG2000 decoding technology for the NVIDIA Fermi-based Quadro® and Tesla™ professional...